Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_006279.5(ST3GAL3):c.83G>A(p.Trp28*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 11 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-43736345-G-A is Pathogenic according to our data. Variant chr1-43736345-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3898041.Status of the report is criteria_provided_single_submitter, 1 stars.
Developmental and epileptic encephalopathy, 15Pathogenic:1
Feb 01, 2024
Neuberg Centre For Genomic Medicine, NCGM
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
The stop gained variant c.83G>A (p.Trp28Ter) in the ST3GAL3 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. Loss of function variants has been previously reported to be disease causing (Indellicato et al., 2020). For these reasons, this variant has been classified as Likely Pathogenic -